Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Small Molecules
Filter     Order     Display # 
Date Item Title
28 Jul 2008 Sucampo Pharmaceuticals Initiates Phase 2 Trial of Cobiprostone for the Treatment of Portal Hypertension in Patients with Liver Cirrhosis
28 Jul 2008 Millennium Advances Oncology Pipeline
28 Jul 2008 Titan Pharmaceuticals Announces Positive Results from Phase III Clinical Trial of Probuphine for the Treatment of Opioid Addiction
28 Jul 2008 Nexavar Approved for Treatment of Liver Cancer in China
28 Jul 2008 Exforge(R) helps nearly twice as many patients control their high blood pressure compared to amlodipine alone
28 Jul 2008 GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Planned Safety Review
26 Jul 2008 Once-yearly Aclasta(R) recommended in EU to treat male osteoporosis and reduce risk of new fractures in patients after hip fracture
26 Jul 2008 Bayer’s Novel Anticoagulant Rivaroxaban Recommended for Approval in the EU
26 Jul 2008 PAION announces dosing of first healthy volunteers in Phase I study with its sedative/anaesthetic CNS 7056
26 Jul 2008 Ceplene(R) Receives Positive European Opinion for Approval From CHMP
26 Jul 2008 Sound Pharmaceuticals, Inc. Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
26 Jul 2008 Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
24 Jul 2008 Phase IV post marketing study results for Totect(R) accepted by the FDA
24 Jul 2008 Progen Terminates Pathway Trial & Confirms Focus on Potencial High Value Molecules and M&A
24 Jul 2008 Supplemental New Drug Application for RISPERDAL(R)CONSTA(R) Submitted to the FDA for the Treatment of Bipolar Disorder
24 Jul 2008 Nexmed Receives FDA Response for Ed Product
24 Jul 2008 Cornerstone Pharmaceuticals Announces Approval to Conduct Phase I/II Clinical Trial of CPI-613 in Cancer Patients by US FDA
24 Jul 2008 MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis
24 Jul 2008 Santhera Receives First Product Approval: Health Canada Approves Catena(r) for Treatment of Friedreich’s Ataxia
24 Jul 2008 Alizyme Announces Headline Results From its European Phase III Clinical Trial of Colal-Pred(R)
24 Jul 2008 Patient recruitment in Phase II trial with MESUPRON(R) (WX-671) in pancreatic cancer patients successfully completed
23 Jul 2008 APOSENSE(R) [18F]-ML-10 for Molecular Imaging of Apoptosis to Proceed to Phase I/II Trials
23 Jul 2008 Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes
23 Jul 2008 Gilead Initiates Phase III Clinical Trial of Elvitegravir, an Investigational Integrase Inhibitor for HIV
23 Jul 2008 MethylGene and Celgene Announce Precautionary Suspension of New Enrollments Into MGCD0103 Clinical Trials
23 Jul 2008 Isotechnika retains global rights to voclosporin
23 Jul 2008 FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
23 Jul 2008 Optimer Pharmaceuticals Completes Enrollment in OPT-80 Phase 3 Clinical Trial in Patients with Clostridium difficile Infection
23 Jul 2008 ZIOPHARM Presents Safety and Preliminary Efficacy Data from Two Phase I Studies of Indibulin at AACR Centennial Conference
23 Jul 2008 Merck & Co., Inc. (MRK)'s JANUMET (TM) Approved in the European Union for Treatment of Type 2 Diabetes
23 Jul 2008 Xanodyne Pharmaceuticals, Inc. Receives Approvable Letter From the U.S. FDA for ZIPSOR(TM) Capsules
23 Jul 2008 Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe
23 Jul 2008 Chelsea Therapeutics Granted MHRA Approval to Begin Phase II Trial of Droxidopa in Fibromyalgia
22 Jul 2008 OncoVista Innovative Therapies to Begin Enrolling Patients in a Phase I/II Study of Cordycepin in Patients with Refractory TdT-Positive Leukemia
22 Jul 2008 Amarin Proceeding to Phase 3 with AMR101 for Hypertriglyceridemia
22 Jul 2008 Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
22 Jul 2008 Threshold Pharmaceuticals Presents Encouraging Interim Results From a Phase 1 Clinical Trial of TH-302 for Solid Tumors At AACR Conference On Translational Medicine
22 Jul 2008 CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
22 Jul 2008 NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients
22 Jul 2008 BioMarin and Summit plc Sign Worldwide Licensing Agreement for Duchenne Muscular Dystrophy Program
22 Jul 2008 BTG plc: Study Shows Abiraterone Can Successfully Treat Aggressive, Chemotherapy-Resistant Prostate Cancer
21 Jul 2008 Curis Selects Hsp90 Inhibitor CUDC-305 as Development Candidate from Targeted Cancer Drug Development Platform
21 Jul 2008 Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
21 Jul 2008 Ambrilia Initiates Phase I/II Clinical Program of its Novel Goserelin Formulation in Prostate Cancer
21 Jul 2008 Exelixis Initiates Phase 3 Trial of XL184 in Medullary Thyroid Cancer
21 Jul 2008 Targacept Initiates Phase 2b Clinical Trial of TC-5214 as Augmentation Treatment in Major Depressive Disorder
19 Jul 2008 Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease
19 Jul 2008 BioNumerik Pharmaceuticals, Inc. Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
17 Jul 2008 Sciele Pharma Announces That the FDA Has Issued an Approvable Letter for the Head Lice Treatment
17 Jul 2008 Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin Phase 3 Study
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 101 - 150 of 5215

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics